Ireland - English - HPRA (Health Products Regulatory Authority)

novo nordisk a/s - somatropin - pdr+solv for soln for inj - 12 units/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

novo nordisk a/s - somatropin r-dna (e.coli expression system) - pdr+solv for soln for inj - 12 international unit

Ireland - English - HPRA (Health Products Regulatory Authority)

novo nordisk a/s - somatropin - pdr+solv for soln for inj - 24 units/ml

India - English - Central Drugs Standard Control Organization

novo nordisk - somatropin - inj - 10mg/1.5ml - vial

India - English - Central Drugs Standard Control Organization

novo nordisk - somatropin - inj - 15mg/1.5ml - vial

India - English - Central Drugs Standard Control Organization

novo nordisk - somatropin - inj - 5mg/1.5ml - vial

New Zealand - English - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - somatropin 12 [iu] - injection with diluent - 12 iu - active: somatropin 12 [iu] excipient: glycine mannitol sodium bicarbonate benzyl alcohol water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - somatropin 4 iu/ml - injection with diluent - 4 iu/ml - active: somatropin 4 iu/ml excipient: glycine mannitol sodium bicarbonate benzyl alcohol water

New Zealand - English - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - somatropin 6.7 mg/ml - solution for injection - 10 mg/1.5ml - active: somatropin 6.7 mg/ml excipient: histidine hydrochloric acid mannitol phenol poloxamer 188 sodium hydroxide water for injection - for the treatment of severe growth failure due to intrauterine growth retardation (i.e. children born small for gestational age [sga] (birth weight and/or length <-2 sd) without spontaneous catch-up growth by 2 years of age).

New Zealand - English - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - somatropin 10 mg/ml - solution for injection - 15 mg/1.5ml - active: somatropin 10 mg/ml excipient: histidine hydrochloric acid mannitol phenol poloxamer 188 sodium hydroxide water for injection - for the treatment of severe growth failure due to intrauterine growth retardation (i.e. children born small for gestational age [sga] (birth weight and/or length <-2 sd) without spontaneous catch-up growth by 2 years of age).